Skip to content

The evaluation of cheese vs milk for stimulating post-prandial and post-exercise muscle protein synthesis

The evaluation of cheese vs milk for stimulating post-prandial and post-exercise muscle protein synthesis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28444
Enrollment
20
Registered
2019-08-07
Start date
2019-08-07
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle mass growth

Interventions

Exercise and milk/cheese protein intake

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Healthy males • Age between 18 and 35 y inclusive • BMI between 18.5 and 30 kg/m2

Exclusion criteria

Exclusion criteria: • Allergies to milk proteins • Lactose intolerant • Smoking • Phenylketonuria • Diabetes Mellitus • Diagnosed GI tract disorders or diseases • Arthritic conditions • A history of neuromuscular problems • Any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications). • Use of certain anticoagulants (use of thrombocyte aggregation inhibitors such as acetylsalicylic acid and carbasalaatcalcium is permitted. Use of other thrombocyte aggregation inhibitors will be discussed with the responsible physician) • Blood donation within 2 months of study initiation • Hypertension (according to WHO criteria) • Recent participation in amino acid tracer studies (less than 1 year ago)

Design outcomes

Primary

MeasureTime frame
MPS and plasma AA availability

Secondary

MeasureTime frame
whole-body protein synthesis, breakdown, oxidation, and net balance, plasma glucose and insulin, and metabolic signalling

Contacts

Public ContactWesley Hermans

Maastricht University, Dep. Human Biology

w.hermans@maastrichtuniversity.nl0433881810

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)